Next Article in Journal
Cancer Cell Lines Are Useful Model Systems for Medical Research
Previous Article in Journal
Role of the RAB7 Protein in Tumor Progression and Cisplatin Chemoresistance
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessReview

Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer

1
Department of Biology, Medical School, University of Crete, Heraklion, Voutes, 71110 Crete, Greece
2
Department of Pathology, Medical School, University of Crete, Heraklion, Voutes, 71110 Crete, Greece
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Cancers 2019, 11(8), 1097; https://doi.org/10.3390/cancers11081097
Received: 20 June 2019 / Revised: 25 July 2019 / Accepted: 30 July 2019 / Published: 1 August 2019
  |  
PDF [1288 KB, uploaded 12 August 2019]
  |     |  

Abstract

Apolipoprotein A-I (ApoA-I), the major protein component of high-density lipoproteins (HDL) is a multifunctional protein, involved in cholesterol traffic and inflammatory and immune response regulation. Many studies revealing alterations of ApoA-I during the development and progression of various types of cancer suggest that serum ApoA-I levels may represent a useful biomarker contributing to better estimation of cancer risk, early cancer diagnosis, follow up, and prognosis stratification of cancer patients. In addition, recent in vitro and animal studies disclose a more direct, tumor suppressive role of ApoA-I in cancer pathogenesis, which involves anti-inflammatory and immune-modulatory mechanisms. Herein, we review recent epidemiologic, clinicopathologic, and mechanistic studies investigating the role of ApoA-I in cancer biology, which suggest that enhancing the tumor suppressive activity of ApoA-I may contribute to better cancer prevention and treatment. View Full-Text
Keywords: apolipoprotein A-I; HDL; cancer; immunity; inflammation; review apolipoprotein A-I; HDL; cancer; immunity; inflammation; review
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Georgila, K.; Vyrla, D.; Drakos, E. Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer. Cancers 2019, 11, 1097.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top